BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways

Current therapeutic options for intrahepatic cholangiocarcinoma (ICC) are very limited, which is largely attributed to poor understanding of molecular pathogenesis of ICC. Breast cancer type 1 susceptibility protein-associated protein-1 (BAP1) has been reported to be a broad-spectrum tumor suppresso...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Death Dis
Main Authors: Chen, Xu-Xiao, Yin, Yue, Cheng, Jian-Wen, Huang, Ao, Hu, Bo, Zhang, Xin, Sun, Yun-Fan, Wang, Jian, Wang, Yu-Peng, Ji, Yuan, Qiu, Shuang-Jian, Fan, Jia, Zhou, Jian, Yang, Xin-Rong
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6179995/
https://ncbi.nlm.nih.gov/pubmed/30305612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-1087-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares